Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tekmira Pharmaceuticals completes phase I clinical trial of ApoB SNALP

Jan. 11, 2010

Tolerx completes enrollment in phase III DEFEND-1 study in type 1 diabetes

Jan. 11, 2010

3SBio applies for registrational trial of Feraheme in China

Jan. 11, 2010

Leptin beneficial in patients with various forms of lipodystrophy

Jan. 11, 2010

Ardea Biosciences reports positive results for RDEA-594 in patients with gout

Jan. 11, 2010

Eisai completes acquisition of AkaRx and its thrombocytopenia drug AKR-501

Jan. 8, 2010

Novartis agreement to supply rhPDGF-BB to BioMimetic amended

Jan. 7, 2010

Phase II investigation of diabetes treatment EGT-0001442 begins

Jan. 7, 2010

Dr. Reddy's Laboratories and Nordic Bioscience report results from phase III balaglitazone trial

Jan. 5, 2010

Novo Nordisk initiates phase I trial of oral insulin analogue NN-1952

Jan. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...